Practice Guidelines for Bipolar Disorder by the <scp>JSMD</scp> (Japanese Society of Mood Disorders)-Reference-Cited by-同舟云学术

Practice Guidelines for Bipolar Disorder by the JSMD (Japanese Society of Mood Disorders)

Published:2024-08-28 Issue: Volume: Page:
ISSN:1323-1316
Container-title:Psychiatry and Clinical Neurosciences
language:en
Short-container-title:Psychiatry Clin Neurosci

Author:

Kato Tadafumi¹^ORCID,Ogasawara Kazuyoshi²,Motomura Keisuke³,Kato Masaki⁴^ORCID,Tanaka Teruaki⁵,Takaesu Yoshikazu⁶^ORCID,Nio Shintaro⁷,Kishi Taro⁸^ORCID,So Mirai⁹,Nemoto Kiyotaka¹⁰^ORCID,Suzuki Eiji¹¹,Watanabe Koichiro¹²^ORCID,Matsuo Koji¹³, , ,

Affiliation:

1. Department of Psychiatry & Behavioral Science Juntendo University Graduate School of Medicine Tokyo Japan

2. Center for Postgraduate Clinical Training and Career Development Nagoya University Hospital Nagoya Japan

3. Clinical Research Division NHO Hizen Psychiatric Medical Center Yoshinogari Japan

4. Department of Neuropsychiatry Kansai Medical University Hirakata Japan

5. Deparment of Psychiatry KKR Sapporo Medical Center Sapporo Japan

6. Department of Neuropsychiatry, Graduate school of Medicine University of the Ryukyus Nishihara Japan

7. Department of Psychiatry Saiseikai Central Hospital Tokyo Japan

8. Department of Psychiatry Fujita Health University School of Medicine Toyoake Japan

9. Department of Psychiatry Tokyo Dental College Tokyo Japan

10. Department of Psychiatry, Institute of Medicine University of Tsukuba Tsukuba Japan

11. Division of Psychiatry Tohoku Medical and Pharmaceutical University Sendai Japan

12. Department of Neuropsychiatry Kyorin University Faculty of Medicine Mitaka Japan

13. Department of Psychiatry, Faculty of Medicine Saitama Medical University Moroyama Japan

Abstract

The Japanese Society of Mood Disorders (JSMD) published treatment guidelines of bipolar disorder in 2011. The present guidelines incorporating new findings were developed to comply to the guidelines of the National Academy of Medicine (NAM) by utilizing systematic reviews and meta‐analysis and taking patient and family opinions as well as insights from multiple professional fields into account. They support combination therapy using mood stabilizers and second‐generation antipsychotics in many aspects. They also have limitations, including the grouping of mood stabilizers and second‐generation antipsychotics when meta‐analysis was performed despite their distinct properties, due to the scarcity of drug‐specific evidence. Despite the limitations, these guidelines provide clinical decision support for psychiatrists in Japan.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pcn.13724

Reference131 articles.

1. Committee for Treatment Guidelines of mood disorders JSMD. Guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012;Kanba S;Psychiatry Clin. Neurosci.,2013

2. Canadian network for mood and anxiety treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder;Yatham LN;Bipolar Disord.,2018

3. World Health Organization.International Classification of Diseases 11th Revision.

4. Mixed features of depression: Why DSM‐5 is wrong (and so was DSM‐IV);Koukopoulos A;Br. J. Psychiatry,2013

5. Long‐term remission and recovery in bipolar disorder: A review;Goldberg JF;Curr. Psychiatry Rep.,2005